Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14913-14920
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14913
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14913
Mucin/sugar | Group 1 | n | Group 4 | n | P value |
MUC1 foveola | 2.93 ± 5.13 | 28 | 9.89 ± 4.17 | 19 | < 0.0001 |
MUC1 glands | 2.57 ± 4.50 | 28 | 7.63 ± 4.60 | 19 | < 0.0001 |
MUC4 foveola | 2.79 ± 4.22 | 14 | 4.59 ± 3.77 | 17 | 0.221 |
MUC4 glands | 5.50 ± 3.14 | 14 | 4.00 ± 4.12 | 17 | 0.286 |
MUC17 foveola | 11.05 ± 3.65 | 21 | 6.93 ± 4.00 | 22 | < 0.0001 |
MUC17 glands | 10.29 ± 4.67 | 21 | 8.00 ± 3.48 | 22 | < 0.0001 |
SNA foveola | 2.00 ± 2.63 | 16 | 6.17 ± 4.69 | 18 | 0.004 |
SNA glands | 2.69 ± 4.01 | 16 | 3.94 ± 5.45 | 18 | 0.457 |
ECA foveola | 13.27 ± 3.08 | 26 | 13.06 ± 4.06 | 18 | 0.846 |
ECA glands | 5.62 ± 4.37 | 26 | 8.00 ± 5.15 | 18 | 0.107 |
-
Citation: Niv Y, Boltin D, Halpern M, Cohen M, Levi Z, Vilkin A, Morgenstern S, Manugian V, Lawrence ES, Gagneux P, Kaur S, Sharma P, Batra SK, Ho SB. Membrane-bound mucins and mucin terminal glycans expression in idiopathic or
Helicobacter pylori , NSAID associated peptic ulcers. World J Gastroenterol 2014; 20(40): 14913-14920 - URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14913.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14913